Date | Time | Source | Announcement |
---|---|---|---|
11 Jul 2008 | 07:00 AM | Customer Agreement | |
14 Apr 2008 | 07:00 AM | Half-yearly Report | |
04 Apr 2008 | 05:20 PM | Director/PDMR Shareholding | |
31 Mar 2008 | 07:00 AM | Total Voting Rights | |
10 Mar 2008 | 03:12 PM | Issue of Equity | |
31 Jan 2008 | 11:36 AM | Total Voting Rights | |
07 Jan 2008 | 10:50 AM | Re Agreement | |
02 Jan 2008 | 05:14 PM | Issue of Equity | |
31 Dec 2007 | 07:00 AM | Total Voting Rights | |
14 Dec 2007 | 03:30 PM | Acquisition(s) | |
14 Dec 2007 | 03:05 PM | AGM Statement | |
21 Nov 2007 | 07:01 AM | Notice of AGM | |
14 Nov 2007 | 09:08 AM | Acquisition | |
09 Nov 2007 | 04:59 PM | Directorate Appointment | |
25 Sep 2007 | 07:00 AM | Final Results | |
03 Sep 2007 | 07:00 AM | Re Agreement | |
14 Aug 2007 | 03:59 PM | AIM Rule 26 Information | |
13 Aug 2007 | 07:00 AM | Re Agreement | |
31 Jul 2007 | 03:37 PM | Total Voting Rights | |
26 Jul 2007 | 09:53 AM | Issue of Equity | |
05 Jul 2007 | 07:00 AM | Re Agreement | |
25 Apr 2007 | 04:29 PM | Holding(s) in Company | |
10 Apr 2007 | 11:59 AM | Director Shareholding | |
05 Apr 2007 | 12:13 PM | Total Voting Rights | |
04 Apr 2007 | 07:00 AM | Placing and Appointment of joint broker | |
04 Apr 2007 | 07:00 AM | Product Launch | |
30 Jan 2007 | 01:51 PM | Interim Results | |
21 Dec 2006 | 08:44 AM | Total Voting Rights | |
29 Nov 2006 | 07:00 AM | Re Agreement | |
20 Oct 2006 | 03:40 PM | Change of accounting ref date | |
11 Oct 2006 | 11:12 AM | Annual Report and Accounts | |
19 Sep 2006 | 07:00 AM | Re Agreement | |
24 Aug 2006 | 07:00 AM | Collaboration Agreement | |
09 Aug 2006 | 08:03 AM | Supplementary consideration shares | |
08 Aug 2006 | 08:00 AM | First Day of Dealings | |
07 Aug 2006 | 12:58 PM | Result of EGM | |
14 Jul 2006 | 02:20 PM | Final Results | |
14 Jul 2006 | 12:00 PM | Propsd Aqstn & notice of EGM | |
13 Jul 2006 | 09:30 AM | Stmnt re Proposed Transaction | |
07 Jul 2006 | 04:07 PM | Directorate Change | |
05 May 2006 | 11:24 AM | Result of EGM | |
19 Apr 2006 | 03:13 PM | Further re Issue of Equity | |
19 Apr 2006 | 08:08 AM | Holding(s) in Company | |
13 Apr 2006 | 05:28 PM | Holding(s) in Company | |
12 Apr 2006 | 07:44 AM | Issue of Equity | |
09 Mar 2006 | 02:19 PM | Holding(s) in Company | |
26 Jan 2006 | 08:23 AM | Interim Results | |
24 Aug 2005 | 07:00 AM | Final Results | |
25 Jul 2005 | 07:57 AM | Board change & trading update | |
17 Jun 2005 | 11:09 AM | Business Strategy |
Avacta Group plc is a United Kingdom-based life sciences company focused on improving healthcare outcomes through targeted cancer treatments and diagnostics. The Company has two segments: Therapeutics and Diagnostics. The Therapeutics segment is a clinical stage oncology biotech division harnessing therapeutic platforms to develop novel, highly targeted cancer drugs. The Diagnostics segment is focused on supporting healthcare professionals and broadening access to diagnostics.
It has two platforms: preICISION and Affimer. The Company's preICISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preICISION platform harnesses this tumor specific protease to activate preICISION peptide drug conjugates and preICISION antibody/Affimer drug conjugates in the tumor microenvironment. Its lead preICISION program AVA6000, a peptide drug conjugate form of doxorubicin, is in Phase 1 studies.
Avacta Group share price launched at 5,448p in 2003.